CLINICAL INNOVATION ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About CLINICAL INNOVATION ApS
CLINICAL INNOVATION ApS (CVR number: 29924880) is a company from HOLBÆK. The company recorded a gross profit of 2310.3 kDKK in 2023. The operating profit was 157.7 kDKK, while net earnings were -7.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was 1.9 %, which can be considered weak but Return on Equity (ROE) was -0.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 43.9 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. CLINICAL INNOVATION ApS's liquidity measured by quick ratio was 0.6 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 3 732.00 | 3 558.00 | 4 111.51 | 3 413.23 | 2 310.35 |
EBIT | 129.00 | 908.00 | 876.44 | 186.82 | 157.66 |
Net earnings | 15.00 | 589.00 | 561.56 | 40.72 | -7.40 |
Shareholders equity total | 3 044.00 | 3 563.00 | 3 629.05 | 3 669.77 | 3 662.37 |
Balance sheet total (assets) | 7 575.00 | 7 369.00 | 7 524.68 | 8 121.86 | 8 336.39 |
Net debt | 1 889.00 | 748.00 | 1 189.10 | 2 247.19 | 2 364.45 |
Profitability | |||||
EBIT-% | |||||
ROA | 1.7 % | 12.2 % | 11.8 % | 2.4 % | 1.9 % |
ROE | 0.5 % | 17.8 % | 15.6 % | 1.1 % | -0.2 % |
ROI | 2.5 % | 18.8 % | 18.1 % | 3.3 % | 2.6 % |
Economic value added (EVA) | - 113.06 | 531.34 | 471.55 | -36.03 | -64.62 |
Solvency | |||||
Equity ratio | 40.2 % | 48.4 % | 48.2 % | 45.2 % | 43.9 % |
Gearing | 70.2 % | 25.4 % | 43.7 % | 65.5 % | 69.3 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 0.5 | 0.6 | 0.7 | 0.5 | 0.6 |
Current ratio | 1.5 | 1.8 | 1.8 | 1.6 | 1.6 |
Cash and cash equivalents | 248.00 | 156.00 | 398.05 | 156.14 | 174.62 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | A | A | BBB | BBB |
Variable visualization
Roles
Companies in the same industry
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.